Abstract
Background
Multisystem inflammatory syndrome in children (MIS-C) is associated with SARS-CoV-2. Long-term consequences of MIS-C remain unknown. The objective was to describe the prevalence and clinical predictors of hypertension (HTN) and elevated blood pressure (BP) following MIS-C.
Methods
A retrospective study of children ≤ 18 years admitted to a tertiary center with MIS-C was performed. HTN and elevated BP were classified as per the 2017 American Academy of Pediatrics Clinical Practice Guidelines and indexed to the 95th percentile. Data included demographics, inpatient clinical measures, and echocardiograms over 1-year follow-up. Data were analyzed using Kruskal–Wallis, chi-square, and logistic regression.
Results
Among 63 children hospitalized with MIS-C (mean age 9.7 ± 4.2 years, 58.7% male, body mass index (BMI) z-score 0.59 ± 1.9), 14% had HTN, and 4% had elevated BP > 30 days post-hospitalization. Multivariate linear regression analysis showed that BMI z-score was significantly associated with higher mean systolic (β = 2.664, CI = 1.307–3.980, p < 0.001) and diastolic (β = 2.547, CI = 0.605–4.489, p = 0.012) BP index > 30 days post-hospitalization. Acute kidney injury (AKI) (23.8%) (OR = 2.977, CI = 1.778–4.987, p < 0.001), peak inpatient serum creatinine (OR = 2.524, CI = 1.344–4.740, p = 0.004), and maximum CRP (OR = 1.009, CI = 1.002–1.016, p = 0.014) were all associated with increased odds of post-hospitalization HTN. Left ventricular hypertrophy was present in 46% while hospitalized, compared to 10% at last follow-up. All had return of normal systolic function.
Conclusions
Post-hospitalization HTN and elevated BP may be associated with MIS-C. Children with greater BMI or AKI may be at greater risk for developing HTN after MIS-C. MIS-C follow-up requires careful BP monitoring and antihypertensive medication consideration.
Graphical abstract
Similar content being viewed by others
Data availability
Available upon request.
References
CDC (2021) HAN archive - 00432. In: Health Alert Network (HAN). https://emergency.cdc.gov/han/2020/han00432.asp. Accessed 3 Jul 2023
Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, Barranco MA, Maxted AM, Rosenberg ES, Easton D, Udo T, Kumar J, Pulver W, Smith L, Hutton B, Blog D, Zucker H, New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team (2020) Multisystem inflammatory syndrome in children in New York state. N Engl J Med 383:347–358. https://doi.org/10.1056/NEJMoa2021756
Basalely A, Gurusinghe S, Schneider J, Shah SS, Siegel LB, Pollack G, Singer P, Castellanos-Reyes LJ, Fishbane S, Jhaveri KD, Mitchell E, Merchant K, Capone C, Gefen AM, Steinberg J, Sethna CB (2021) Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19. Kidney Int 100:138–145. https://doi.org/10.1016/j.kint.2021.02.026
Valverde I, Singh Y, Sanchez-de-Toledo J, Theocharis P, Chikermane A, Di Filippo S, Kucinska B, Mannarino S, Tamariz-Martel A, Gutierrez-Larraya F, Soda G, Vandekerckhove K, Gonzalez-Barlatay F, McMahon CJ, Marcora S, Napoleone CP, Duong P, Tuo G, Deri A et al (2021) Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation 143:21–32. https://doi.org/10.1161/CIRCULATIONAHA.120.050065
Parr SK, Siew ED (2016) Delayed consequences of acute kidney injury. Adv Chronic Kidney Dis 2:186–194. https://doi.org/10.1053/j.ackd.2016.01.014
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, de Ferranti SD, Fulton DR, Burns JC, Newburger JW (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5:e003289. https://doi.org/10.1161/JAHA.116.003289
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385. https://doi.org/10.1161/01.cir.94.6.1379
Hsu CY, Hsu RK, Yang J, Ordonez JD, Zheng S, Go AS (2016) Elevated BP after AKI. J Am Soc Nephrol 27:914–923. https://doi.org/10.1681/ASN.2014111114
Flynn JT, Kaelber DC, Baker-Smith CM, Subcommittee on Screening and Management of High Blood Pressure in Children et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. https://doi.org/10.1542/peds.2018-1739
Kidney Disease Improving Global Outcomes (2012) Summary of Recommendation Statements. Kidney Int Suppl 2:8–12. https://doi.org/10.1038/kisup.2012.7
Sluysmans T, Colan SD (2016) Structural measurements and adjustments for growth. In: Echocardiography in Pediatric and Congenital Heart Disease. John Wiley & Sons, Ltd, Oxford, UK, pp 61–72
Colan SD (2012) Normal echocardiographic values for cardiovascular structure. In: Lai WW, Mertens LL, Geva T, Cohen MS. Echocardiography in Pediatric and Congenital Heart Disease: From Fetus to Adult. John Wiley & Sons
Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714. https://doi.org/10.1016/j.echo.2009.03.003
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999. https://doi.org/10.1161/CIR.0000000000000484
Tadic M, Cuspidi C, Mancia G, Dell’Oro R, Grassi G (2020) COVID-19, hypertension and cardiovascular diseases: should we change the therapy? Pharmacol Res 158:104906. https://doi.org/10.1016/j.phrs.2020.104906
Barekat M, Shahrbaf MA, Rahi K, Vosough M (2022) Hypertension in COVID-19, a risk factor for infection or a late consequence? Cell J 24:424–426. https://doi.org/10.22074/cellj.2022.8487
Chen G, Li X, Gong Z, Xia H, Wang Y, Wang X, Huang Y, Barajas-Martinez H, Hu D (2021) Hypertension as a sequela in patients of SARS-CoV-2 infection. PLos One 16:e0250815. https://doi.org/10.1371/journal.pone.0250815
Jackson SL, Zhang Z, Wiltz JL, Loustalot F, Ritchey MD, Goodman AB, Yang Q (2018) Hypertension among youths—United States, 2001–2016. Am J Transplant 18:2356–2360. https://doi.org/10.1111/ajt.15050
Song P, Zhang Y, Yu J, Zha M, Zhu Y, Rahimi K, Rudan I (2019) Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr 173:1154–1163. https://doi.org/10.1001/jamapediatrics.2019.3310
Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, Garcia-May PK, Mhatre M, Usman MA, Abd-Elsalam S, Etuk S, Simmons LE, Napolitano R, Deantoni S, Liu B, Prefumo F, Savasi V, do Vale MS, Baafi E, Zainab G, Nieto R, et al (2021) Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol 225:e281–e289. https://doi.org/10.1016/j.ajog.2021.05.014
Parker ED, Sinaiko AR, Kharbanda EO, Margolis KL, Daley MF, Trower NK, Sherwood NE, Greenspan LC, Lo JC, Magid DJ, O’Connor PJ (2016) Change in weight status and development of hypertension. Pediatrics 137:e20151662. https://doi.org/10.1542/peds.2015-1662
Whitworth JA (1992) Adrenocorticotrophin and steroid-induced hypertension in humans. Kidney Int (Suppl 37):S34-S37. https://www.ncbi.nlm.nih.gov/pubmed/1321309
Everett B, Zajacova A (2015) Gender differences in hypertension and hypertension awareness among adults. Biodemography Soc Biol 61:1–17. https://doi.org/10.1080/19485565.2014.929488
Theocharis R, Wong J, Pushparajah K, Mathur SK, Simpson JM, Pascall E, Cleary A, Stewart K, Adhvaryu K, Savis A, Kabir SR, Uy MP, Heard H, Peacock K, Miller O (2021) Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. Eur Heart J Cardiovasc Imaging 22:896–903. https://doi.org/10.1093/ehjci/jeaa212
Belhadjer Z, Meot M, Bajolle F, Khraiche D, Legendre A, Abakka S, Auriau J, Grimaud M, Oualha M, Beghetti M, Wacker J, Ovaert C, Hascoet S, Selegny M, Malekzadeh-Milani S, Maltret A, Bosser G, Giroux N, Bonnemains L et al (2020) Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation 142:429–436. https://doi.org/10.1161/CIRCULATIONAHA.120.048360
Kobayashi R, Dionne A, Ferraro A, Harrild D, Newburger J, VanderPluym C, Gauvreau K, Son MB, Lee P, Baker A, de Ferranti S, Friedman KG (2021) Detailed assessment of left ventricular function in multisystem inflammatory syndrome in children, using strain analysis. CJC Open 3:880–887. https://doi.org/10.1016/j.cjco.2021.02.012
Rao G (2016) Diagnosis, epidemiology, and management of hypertension in children. Pediatrics 138. https://doi.org/10.1542/peds.2015-3616
Yang L, Magnussen CG, Yang L, Bovet P, Xi B (2020) Elevated blood pressure in childhood or adolescence and cardiovascular outcomes in adulthood: a systematic review. Hypertension 75:948–955. https://doi.org/10.1161/HYPERTENSIONAHA.119.14168
Funding
Dr. Sethna is supported by NIH/NIDDK R01DK131091.
Author information
Authors and Affiliations
Contributions
All authors conceptualized and designed the study and critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. Conceptualization: J.L. and C.S.; methodology: J.L. and C.S.; formal analysis: J.L., C.S., and M.S.; data curation: J.L., M.S., C.S., E.M., and C.C.; writing—original draft preparation: J.L.; writing—review and editing: J.L., M.S., C.S., E.M., and C.C; supervision: C.S.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was approved by the Institutional Review Board of Northwell Health. Consent from a guardian/parent and assent from children ≥ 7 years were obtained for the prospective piece of this study.
Consent for publication
N/A.
Competing interests
Dr. Sethna was on an advisory board for Travere Therapeutics. All other authors have no conflicting interests to disclose.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lehman, J.R., Schuchman, M., Mitchell, E. et al. Hypertension after multisystem inflammatory syndrome in children (MIS-C). Pediatr Nephrol 38, 4083–4091 (2023). https://doi.org/10.1007/s00467-023-06061-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-023-06061-2